Not applicableStudy completedNCT07052734What this trial is testingMiti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer PatientsWho this might be right forBreast Cancer Sun Yat-sen University 2,843
Not applicableStudy completedNCT00433407What this trial is testingT-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsWho this might be right forBreast CancerLung CancerOvarian Cancer+3 more Jonsson Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06518837What this trial is testingTirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerWho this might be right forHormone Receptor-Positive Breast CancerHER2-Negative Breast Cancer Rutgers, The State University of New Jersey 40
Not applicableStudy completedNCT05377684What this trial is testingStudy of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer TreatmentWho this might be right forEarly-stage Breast Cancer Ipsen 450
Testing effectiveness (Phase 2)UnknownNCT04247633What this trial is testingHigh Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)Who this might be right forBreast Cancer Samsung Medical Center 578
Testing effectiveness (Phase 2)Study completedNCT02273973What this trial is testingNeoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)Who this might be right forBreast Cancer Genentech, Inc. 334
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630948What this trial is testingAdherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast CancerWho this might be right forBreast CancerAdherence, Medication Institute of Oncology Ljubljana 90
Testing effectiveness (Phase 2)Study completedNCT01142778What this trial is testingBevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07317778What this trial is testingChemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast CancerWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3)HR Positive/HER2 Low Breast Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 249
Post-approval studies (Phase 4)Active Not RecruitingNCT04928261What this trial is testingEvaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic TherapyWho this might be right forBreast Cancer Ottawa Hospital Research Institute 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04398914What this trial is testingPyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast CancerWho this might be right forBreast Cancer Invasive Shanghai Jiao Tong University School of Medicine 216
Post-approval studies (Phase 4)UnknownNCT05036005What this trial is testingNeoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)Who this might be right forBreast CancerBreast NeoplasmsBreast Cancer Female+1 more Institut fuer Frauengesundheit 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117What this trial is testingPertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast CancerWho this might be right forBreast Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Very early researchStudy completedNCT02802748What this trial is testingPhase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)Who this might be right forBreast Cancer SOLTI Breast Cancer Research Group 60
Not applicableLooking for participantsNCT07215364What this trial is testingImpact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 InhibitorsWho this might be right forEarly-stage Breast Cancer Spanish Breast Cancer Research Group 74
Testing effectiveness (Phase 2)Study completedNCT00629499What this trial is testingNanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast CancerWho this might be right forBreast Cancer SCRI Development Innovations, LLC 63
Testing effectiveness (Phase 2)Ended earlyNCT01754519What this trial is testingRadiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing SurgeryWho this might be right forDuctal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more Roswell Park Cancer Institute 1
Large-scale testing (Phase 3)Study completedNCT03013504What this trial is testingA Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer PatientsWho this might be right forHER2 Positive Breast Cancer Prestige Biopharma Limited 503
Not applicableWithdrawnNCT07136493What this trial is testingCirculating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more City of Hope Medical Center
Not applicableEnded earlyNCT03137693What this trial is testingPreoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast CancerWho this might be right forBreast CancerBreast Cancer FemaleBreast Adenocarcinoma H. Lee Moffitt Cancer Center and Research Institute 20